Patents Assigned to E-NA BIOTEC INC.
  • Patent number: 11041152
    Abstract: The purpose of the present invention is to provide novel miR-143 derivatives described herein that can be used as oligonucleotide therapeutics.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: June 22, 2021
    Assignees: E-NA BIOTEC INC.
    Inventors: Yukihiro Akao, Yukio Kitade, Mitsuaki Sekiguchi, Yasunori Mitsuoka, Akira Kugimiya, Yasuo Sasaki